Stephen Ondra Named Amida Technology Solutions Chief Strategy Officer; Peter Levin Comments

Stephen Ondra
Stephen Ondra

Stephen Ondra, formerly senior vice president and chief medical officer at health insurer Health Care Service Corp., has joined Maryland-based open-source software firm Amida Technology Solutions as chief strategy officer.

Peter Levin, founder and CEO of Amida, said in a statement released Thursday Ondra’s leadership experience in both private and public health sectors complements Amida’s efforts to leverage data to help individuals make informed decisions about their health care.

The U.S. Army veteran previously served as chief medical officer of Northwestern Memorial Hospital, health information technology co-chair at the White House’s National Science and Technology Council and senior health policy adviser to secretary of the Department of Veterans Affairs.

He spent 13 years as professor of neurological surgery at Northwestern University, where he also served as acting chair of neurological surgery at the university’s Feinberg School of Medicine.

Amida works to provide health care institutions, government and international development agencies with data security, information management and data interoperability platforms such as Data Reconciliation Engine and Orange Rx.

The Data Reconciliation Engine is an open-source tool that works to extract medical data from various sources, while Orange Rx is a mobile application designed to help users manage medications and integrate data with electronic health record systems.

Check Also

SAIC

SAIC Awarded TSA Test & Evaluation Support BPA

Science Applications International Corp. (NYSE: SAIC) has been awarded a potential $40M blanket purchase agreement for operational test and evaluation services to the Transportation Security Administration, according to an award notice posted Thursday.

US Air Force

Air Force Selects Boeing, Lockheed, Raytheon Technologies for Hypersonic Cruise Missile Tech Design Program

The U.S. Air Force has indicated its intent to solicit design proposals from Boeing (NYSE: BA), Lockheed Martin (NYSE: LMT) and Raytheon Technologies (NYSE: RTX) for a hypersonic cruise missile technology that can be launched from a fighter or a bomber aircraft.